The University of Chicago Header Logo

Connection

Christopher Shea to Skin Neoplasms

This is a "connection" page, showing publications Christopher Shea has written about Skin Neoplasms.
Connection Strength

8.185
  1. Acrochordon With Histological Features of Lichen Sclerosus. Am J Dermatopathol. 2019 Jun; 41(6):e64-e65.
    View in: PubMed
    Score: 0.491
  2. Update on Thin Melanoma: Outcome of an International Workshop. Adv Anat Pathol. 2016 Jan; 23(1):24-9.
    View in: PubMed
    Score: 0.387
  3. Melanocytic tumors with intraepidermal melanophages: a report of five cases with review of 231 archived cutaneous melanocytic tumors. J Cutan Pathol. 2015 Jun; 42(6):394-9.
    View in: PubMed
    Score: 0.367
  4. Melanocytes, melanocyte stem cells, and melanoma stem cells. Clin Dermatol. 2013 Mar-Apr; 31(2):166-78.
    View in: PubMed
    Score: 0.318
  5. Clinical decision making based on histopathologic grading and margin status of dysplastic nevi. Arch Dermatol. 2012 Feb; 148(2):259-60.
    View in: PubMed
    Score: 0.295
  6. Lentigo maligna: melanoma in situ on chronically sun-damaged skin. Arch Pathol Lab Med. 2011 Jul; 135(7):838-41.
    View in: PubMed
    Score: 0.283
  7. The recurrent nevus phenomenon: a history of challenge, controversy, and discovery. Arch Pathol Lab Med. 2011 Jul; 135(7):842-6.
    View in: PubMed
    Score: 0.283
  8. Immunohistochemistry of melanocytic proliferations. Arch Pathol Lab Med. 2011 Jul; 135(7):853-9.
    View in: PubMed
    Score: 0.283
  9. Arsenical keratoses in Bangladesh--update and prevention strategies. Dermatol Clin. 2011 Jan; 29(1):45-51.
    View in: PubMed
    Score: 0.274
  10. Benign versus malignant parakeratosis: a nuclear morphometry study. Mod Pathol. 2010 Jun; 23(6):799-803.
    View in: PubMed
    Score: 0.258
  11. KSHV/HHV8-associated primary cutaneous plasmablastic lymphoma in a patient with Castleman's disease and Kaposi's sarcoma. J Cutan Pathol. 2006 Sep; 33 Suppl 2:46-51.
    View in: PubMed
    Score: 0.203
  12. Multiple subcutaneous nodules with unknown metastases to the liver--quiz case. Arch Dermatol. 2005 Jan; 141(1):93-8.
    View in: PubMed
    Score: 0.181
  13. Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions? Am J Clin Pathol. 2003 Aug; 120(2):203-8.
    View in: PubMed
    Score: 0.164
  14. Impact of Next-generation Sequencing on Interobserver Agreement and Diagnosis of Spitzoid Neoplasms. Am J Surg Pathol. 2021 12 01; 45(12):1597-1605.
    View in: PubMed
    Score: 0.146
  15. CD34 expression in desmoplastic melanoma. J Cutan Pathol. 2001 Nov; 28(10):508-12.
    View in: PubMed
    Score: 0.145
  16. Maturing papillomatous nevoid melanoma in the scalp mimicking recurrent melanocytic nevus: A case report of previously undescribed subtype of nevoid melanoma. Pathol Int. 2022 Jan; 72(1):59-64.
    View in: PubMed
    Score: 0.145
  17. Primary chondroid melanoma. J Cutan Pathol. 2001 Oct; 28(9):482-5.
    View in: PubMed
    Score: 0.144
  18. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation. J Cutan Pathol. 2001 Sep; 28(8):400-6.
    View in: PubMed
    Score: 0.143
  19. Recurrent papules on the left upper extremity of a 50-year-old man. Arch Dermatol. 2001 Mar; 137(3):365-70.
    View in: PubMed
    Score: 0.138
  20. Malignant melanoma with paradoxical maturation. Am J Surg Pathol. 2000 Dec; 24(12):1600-14.
    View in: PubMed
    Score: 0.136
  21. Role of Wnt signaling in dermatofibroma induction phenomenon. J Cutan Pathol. 2021 Feb; 48(2):217-220.
    View in: PubMed
    Score: 0.135
  22. Keratotic melanocytic nevus: a clinicopathologic and immunohistochemical study. J Cutan Pathol. 2000 Aug; 27(7):344-50.
    View in: PubMed
    Score: 0.133
  23. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans? Am J Surg Pathol. 2000 Jul; 24(7):996-1003.
    View in: PubMed
    Score: 0.132
  24. Up-Regulation of PARP1 Expression Significantly Correlated with Poor Survival in Mucosal Melanomas. Cells. 2020 05 05; 9(5).
    View in: PubMed
    Score: 0.131
  25. Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas. Nat Commun. 2020 04 14; 11(1):1806.
    View in: PubMed
    Score: 0.130
  26. Trichoepithelioma: a 19-year clinicopathologic re-evaluation. J Cutan Pathol. 1999 Sep; 26(8):398-404.
    View in: PubMed
    Score: 0.125
  27. Selected cutaneous vascular neoplasms. A review. Dermatol Clin. 1999 Jul; 17(3):507-20, viii.
    View in: PubMed
    Score: 0.123
  28. Recent developments in the pathology of melanocytic neoplasia. Dermatol Clin. 1999 Jul; 17(3):615-30, ix.
    View in: PubMed
    Score: 0.123
  29. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature. JAMA Dermatol. 2017 10 01; 153(10):999-1006.
    View in: PubMed
    Score: 0.109
  30. Scaly erythematous lesion in a patient with extensive solar damage. Malignant melanoma in situ, amelanotic type. Arch Dermatol. 1996 Oct; 132(10):1239, 1242.
    View in: PubMed
    Score: 0.102
  31. CD34-reactive fibrous papule of the nose. J Am Acad Dermatol. 1996 Aug; 35(2 Pt 2):342-5.
    View in: PubMed
    Score: 0.101
  32. Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 Cases. Am J Dermatopathol. 2016 Jul; 38(7):499-503.
    View in: PubMed
    Score: 0.100
  33. Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group. J Am Acad Dermatol. 2016 Aug; 75(2):356-63.
    View in: PubMed
    Score: 0.099
  34. Differential expression of CD44 in malignant cutaneous epithelial neoplasms. Am J Dermatopathol. 1995 Oct; 17(5):447-51.
    View in: PubMed
    Score: 0.095
  35. Early morphea simulating patch-stage mycosis fungoides. Am J Dermatopathol. 2015 May; 37(5):409-12.
    View in: PubMed
    Score: 0.092
  36. Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanoma. J Cutan Pathol. 2015 Apr; 42(4):244-52.
    View in: PubMed
    Score: 0.092
  37. Angiotropic metastatic malignant melanoma. Am J Dermatopathol. 1995 Feb; 17(1):58-62.
    View in: PubMed
    Score: 0.091
  38. CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans. J Cutan Pathol. 1994 Aug; 21(4):324-9.
    View in: PubMed
    Score: 0.088
  39. Mast cells in angiolipomas and hemangiomas of human skin: are they important for angiogenesis? J Cutan Pathol. 1994 Jun; 21(3):247-51.
    View in: PubMed
    Score: 0.087
  40. Eruptive cutaneous squamous cell carcinoma and psoriasis: response to cetuximab. Clin Exp Dermatol. 2014 Jul; 39(5):604-7.
    View in: PubMed
    Score: 0.086
  41. Baseline comorbidities in a skin cancer prevention trial in Bangladesh. Eur J Clin Invest. 2013 Jun; 43(6):579-88.
    View in: PubMed
    Score: 0.080
  42. Overexpression of p53 protein in basal cell carcinomas of human skin. Am J Pathol. 1992 Jul; 141(1):25-9.
    View in: PubMed
    Score: 0.076
  43. Expression of MiTF may be helpful in differentiating cellular neurothekeoma from plexiform fibrohistiocytic tumor (histiocytoid predominant) in a partial biopsy specimen. Am J Dermatopathol. 2012 Apr; 34(2):157-60.
    View in: PubMed
    Score: 0.075
  44. PTEN positively regulates UVB-induced DNA damage repair. Cancer Res. 2011 Aug 01; 71(15):5287-95.
    View in: PubMed
    Score: 0.071
  45. Granulomatous eruption after BCG vaccine immunotherapy for malignant melanoma. J Am Acad Dermatol. 1989 Nov; 21(5 Pt 2):1119-22.
    View in: PubMed
    Score: 0.063
  46. PAX3 expression in primary melanomas and nevi. Mod Pathol. 2008 May; 21(5):525-30.
    View in: PubMed
    Score: 0.056
  47. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus"). Am J Surg Pathol. 2008 Jan; 32(1):36-44.
    View in: PubMed
    Score: 0.056
  48. Cutaneous clear-cell granular cell tumors: the histologic description of an unusual variant. J Cutan Pathol. 2007 May; 34(5):397-404.
    View in: PubMed
    Score: 0.053
  49. Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma. Br J Dermatol. 2006 Nov; 155(5):988-93.
    View in: PubMed
    Score: 0.051
  50. Angiotropism in epidermotropic metastatic melanoma: another clue to the diagnosis. Am J Dermatopathol. 2006 Oct; 28(5):429-33.
    View in: PubMed
    Score: 0.051
  51. Decreased CD117 expression in hypopigmented mycosis fungoides correlates with hypomelanosis: lessons learned from vitiligo. Mod Pathol. 2006 Sep; 19(9):1255-60.
    View in: PubMed
    Score: 0.050
  52. Phase 2 study of the g209-2M melanoma peptide vaccine and low-dose interleukin-2 in advanced melanoma: Cancer and Leukemia Group B 509901. J Immunother. 2006 Jan-Feb; 29(1):95-101.
    View in: PubMed
    Score: 0.048
  53. Pagetoid melanocytosis: when is it significant? Pathology. 2004 Oct; 36(5):435-44.
    View in: PubMed
    Score: 0.044
  54. Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases. Arch Dermatol. 2002 May; 138(5):603-8.
    View in: PubMed
    Score: 0.038
  55. Basal cell carcinoma originating from a nevus sebaceus on the scalp of a 7-year-old boy. J Pediatr Hematol Oncol. 2001 May; 23(4):247-9.
    View in: PubMed
    Score: 0.035
  56. Reassessment of lymphocytic atypia in the diagnosis of mycosis fungoides. Mod Pathol. 2001 Apr; 14(4):285-8.
    View in: PubMed
    Score: 0.035
  57. Utility of step sections: demonstration of additional pathological findings in biopsy samples initially diagnosed as actinic keratosis. Arch Dermatol. 2000 Apr; 136(4):471-5.
    View in: PubMed
    Score: 0.032
  58. Expression of CD34 in sclerotic ("plywood") fibromas. Am J Dermatopathol. 2000 Feb; 22(1):17-21.
    View in: PubMed
    Score: 0.032
  59. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol. 1999 Jul; 23(7):786-94.
    View in: PubMed
    Score: 0.031
  60. Quantitation of intraepidermal T-cell subsets in formalin-fixed, paraffin-embedded tissue helps in the diagnosis of mycosis fungoides. J Cutan Pathol. 1999 Apr; 26(4):169-75.
    View in: PubMed
    Score: 0.030
  61. Immunohistochemical expression of retinoblastoma protein in cutaneous melanomas. Br J Dermatol. 1995 Dec; 133(6):890-5.
    View in: PubMed
    Score: 0.024
  62. Immunohistochemistry of dermatofibromas and benign fibrous histiocytomas. J Cutan Pathol. 1995 Aug; 22(4):336-41.
    View in: PubMed
    Score: 0.024
  63. p53 expression is rare in cutaneous melanomas. Am J Dermatopathol. 1995 Aug; 17(4):344-9.
    View in: PubMed
    Score: 0.024
  64. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res. 1995 Jul 01; 55(13):2713-8.
    View in: PubMed
    Score: 0.023
  65. Immunohistochemical expression of BCL-2 in melanomas and intradermal nevi. J Cutan Pathol. 1994 Oct; 21(5):393-7.
    View in: PubMed
    Score: 0.022
  66. Dual role of SIRT1 in UVB-induced skin tumorigenesis. Oncogene. 2015 Jan 15; 34(3):357-63.
    View in: PubMed
    Score: 0.021
  67. Oncogenes in melanomas. J Dermatol. 1992 Nov; 19(11):853-67.
    View in: PubMed
    Score: 0.019
  68. UVA induces lesions resembling seborrheic keratoses in mice with keratinocyte-specific PTEN downregulation. J Invest Dermatol. 2011 Jul; 131(7):1583-6.
    View in: PubMed
    Score: 0.017
  69. Regulation of global genome nucleotide excision repair by SIRT1 through xeroderma pigmentosum C. Proc Natl Acad Sci U S A. 2010 Dec 28; 107(52):22623-8.
    View in: PubMed
    Score: 0.017
  70. Epidermolytic hyperkeratosis within infundibular cysts. J Cutan Pathol. 2007 Apr; 34(4):360-2.
    View in: PubMed
    Score: 0.013
  71. Follicular mucinosis as a presenting sign of acute myeloblastic leukemia. J Am Acad Dermatol. 1998 May; 38(5 Pt 2):803-5.
    View in: PubMed
    Score: 0.007
  72. Abnormalities of p53 protein expression in cutaneous disorders. Arch Dermatol. 1994 Feb; 130(2):225-32.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.